Figures & data
Notes: Patients were given either a) intravitreal bevacizumab (IVB) as three monthly injections with the final follow-up at month 3 or b) single DEX intravitreal implant with follow-ups at months 1 and 3. BCVA was recorded before injections/implantation and at months 1 and 3; IVB (n=121), DEX implant (n=14).
Abbreviations: BCVA, best-corrected visual acuity; CME, cystoid macular edema; MAR, minimum angle of resolution; DEX, dexamethasone.
Abbreviations: BCVA, best-corrected visual acuity; CME, cystoid macular edema; MAR, minimum angle of resolution; DEX, dexamethasone.
Notes: Patients were given either a) intravitreal bevacizumab (IVB) as three monthly injections with the final follow-up at month 3 or b) single DEX intravitreal implant with follow-ups at months 1 and 3. CRT was recorded before injections/implantation and at months 1 and 3; IVB (n=121), DEX implant (n=14), *p<0.05.
Abbreviations: CRT, central retinal thickness; CME, cystoid macular edema; DEX, dexamethasone.
Abbreviations: CRT, central retinal thickness; CME, cystoid macular edema; DEX, dexamethasone.
Notes: Patients were given either a) intravitreal bevacizumab (IVB) as three monthly injections with the final follow-up at month 3 or b) single DEX intravitreal implant with follow-ups at months 1 and 3. IOP was recorded before injections/implantation and at months 1 and 3; IVB (n=121), DEX implant (n=14); **p<0.01.
Abbreviations: IOP, intraocular pressure; CME, cystoid macular edema; DEX, dexamethasone.
Abbreviations: IOP, intraocular pressure; CME, cystoid macular edema; DEX, dexamethasone.